NYSE:BIO
Bio-Rad Laboratories Inc Stock News
$282.26
+0.460 (+0.163%)
At Close: Jun 14, 2024
HOLMDEL, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host
Why Is Bio-Rad (BIO) Up 7.8% Since Last Earnings Report?
12:36pm, Thursday, 06'th Jun 2024
Bio-Rad (BIO) reported earnings 30 days ago. What's next for the stock?
Aptevo Participating in the BIO International Convention
08:05am, Monday, 03'rd Jun 2024
SEATTLE, WA / ACCESSWIRE / June 3, 2024 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprieta
Identity, Access Management Solutions Provider BIO-key to Participate in Fireside Chat at the Maxim Group Virtual Tech Conference, Tues. June 4th at 9am ET
BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES
07:00am, Friday, 31'st May 2024
MINNEAPOLIS , May 31, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer will present at the following investor confer
ONCOTELIC TO PARTICIPATE AT THE BIO INTERNATIONAL 2024 MEETING
09:55am, Thursday, 30'th May 2024
AGOURA HILLS, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its CEO- Dr. Vuong Trieu will be participating at the BIO International 2024 meeting on
Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group
09:00am, Thursday, 30'th May 2024
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Anette Engelhardt
Lineage to Present at 2024 BIO International Convention
08:00am, Thursday, 30'th May 2024
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell
Enveric Biosciences to Participate in BIO International Convention 2024
08:00am, Thursday, 30'th May 2024
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecul
BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE
07:00am, Thursday, 30'th May 2024
MINNEAPOLIS, May 30, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) will showcase multiple applications of its recently launched MauriceFlex™ System at the 72nd ASMS Conference on Mass S
Protalix BioTherapeutics to Present at the 2024 BIO International Convention
08:38am, Wednesday, 29'th May 2024
Corporate presentation scheduled for Monday, June 3, 2024 at 2:30 P.M. PDT CARMIEL, Israel , May 29, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical com
Virpax® Pharmaceuticals to Present at 2024 BIO International Convention
07:30am, Wednesday, 29'th May 2024
BERWYN, Pa.--(BUSINESS WIRE)-- #pharma--Virpax to Present at 2024 BIO International Convention.
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024
07:00am, Wednesday, 29'th May 2024
Presentation to highlight Company's novel application of AI/machine learning capabilities utilizing its proprietary biobank of more than 150,000 tumor samples to guide leading biopharma partners throu
Acasti Pharma to Attend BIO International Convention 2024
04:05pm, Tuesday, 28'th May 2024
PRINCETON, N.J., May 28, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel, injectable formulation of nim
BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq
04:30pm, Friday, 24'th May 2024
WALL, N.J., May 24, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Ident